The DOI matches its Crossref record.
Characterization of a highly invasive and spontaneously metastatic human malignant melanoma cell line
Abstract
Although the incidence of, and deaths due to, malignant melanoma are rising at a rapid rate, few experimental models mimic the highly metastatic properties associated with the pathogenesis of the human disease, making study of the disease difficult. Thus, new human models are required to understand melanoma biology, especially its metastatic properties. Here we describe C8161, a highly invasive and spontaneously metastatic human melanoma cell line, which grows progressively in the subcutis of athymic nude mice with an average doubling time of approximately 6 days. By the time the tumor reaches a diameter of I cm, amelanotic metastases in lymph nodes, skin, peritoneal wall, spleen and lungs have formed. By comparing C8161 to variants from other well‐characterized human malignant melanomas (A375 and MeWo) with differing metastatic traits, properties presumed to be involved in metastatic propensity were examined. C8161 showed a 2‐ to 14‐fold higher ability to invade reconstituted basement membrane barriers in the MICS and correspondingly high type‐IV collagenase mRNA levels and collagenolytic activity, as compared with other melanoma cell lines. Likewise, differential adhesion to immobilized RBM or HUVEC monolayers was observed, but did not correlate to rank orders of malignant properties. Recently, a correlation between surface expression of ICAM‐I and secondary tumor formation by human melanomas has been described in several laboratories. Basal levels of ICAM‐1 on C8161, A375 and MeWo human melanomas were compared, but no correlation with metastatic potential was noted. Proto‐oncogene expression in C8161 cells was compared with A375P and A375M variants using Northern blot analysis, c‐myc expression was 6‐fold greater than both A375 variants; c‐fos expression was 3.4‐fold less than A375P and 1.7‐fold less than A375M; c‐jun in C8161 cells was 2.5‐fold and 2.1‐fold greater than expression in A375P and A375M, respectively. Because C8161 is so highly malignant, amenable to experimental manipulation, and its behavior in nude mice mimics the clinical course of malignant melanoma, this cell line will prove valuable for studying properties associated with human melanoma tumor progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Vascular Channel Formation by Human Melanoma Cells in Vivo and in Vitro: Vasculogenic Mimicry
Maniotis, A. J., Folberg, R., Hess, A., Seftor, E. A., Gardner, L. M. G., Pe'er, J., Trent, J. M., Meltzer, P. S., & Hendrix, M. J. C. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65173-5 · Cited by 2,043
Self-citationKiSS-1, a Novel Human Malignant Melanoma Metastasis-Suppressor Gene
Lee, J.-H., Miele, M. E., Hicks, D. J., Phillips, K. K., Trent, J. M., Weissman, B. E., & Welch, D. R. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.23.1731 · Cited by 1,072
Self-citationMonoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis
Nomura, D. K., Long, J. Z., Niessen, S., Hoover, H. S., Ng, S.-W., & Cravatt, B. F. (2010) · Cell · doi:10.1016/j.cell.2009.11.027 · Cited by 1,002
“Aggressive cancer lines were confirmed to display much greater in vitro migration and in vivo tumor-growth rates compared to their nonaggressive counterparts (Figure S1 available online), as previously shown (Jessani et al., 2002, 2004; Seftor et al., 2002; Welch et al., 1991).”
Resultαv Integrins as receptors for tumor targeting by circulating ligands
Pasqualini, R., Koivunen, E., & Ruoslahti, E. (1997) · Nature Biotechnology · doi:10.1038/nbt0697-542 · Cited by 744
Embryonic and tumorigenic pathways converge via Nodal signaling: role in melanoma aggressiveness
Topczewska, J. M., Postovit, L.-M., Margaryan, N. V., Sam, A., Hess, A. R., Wheaton, W. W., Nickoloff, B. J., Topczewski, J., & Hendrix, M. J. C. (2006) · Nature Medicine · doi:10.1038/nm1448 · Cited by 438
Self-citationExpression of tissue factor by melanoma cells promotes efficient hematogenous metastasis.
Mueller, B. M., Reisfeld, R. A., Edgington, T. S., & Ruf, W. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.11832 · Cited by 356
Proteasome Inhibitors Trigger NOXA-Mediated Apoptosis in Melanoma and Myeloma Cells
Qin, J.-Z., Ziffra, J., Stennett, L., Bodner, B., Bonish, B. K., Chaturvedi, V., Bennett, F., Pollock, P. M., Trent, J. M., Hendrix, M. J. C., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0676 · Cited by 336
Self-citationYang, E. V., Kim, S.-J., Donovan, E. L., Chen, M., Gross, A. C., Webster Marketon, J. I., Barsky, S. H., & Glaser, R. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.10.005 · Cited by 317
Lee, L. M. J., Seftor, E. A., Bonde, G., Cornell, R. A., & Hendrix, M. J. C. (2005) · Developmental Dynamics · doi:10.1002/dvdy.20471 · Cited by 295
Self-citationPostovit, L.-M., Margaryan, N. V., Seftor, E. A., Kirschmann, D. A., Lipavsky, A., Wheaton, W. W., Abbott, D. E., Seftor, R. E. B., & Hendrix, M. J. C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800467105 · Cited by 286
Self-citationMa, X.-H., Piao, S., Wang, D., Mcafee, Q. W., Nathanson, K. L., Lum, J. J., Li, L. Z., & Amaravadi, R. K. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2372 · Cited by 234
Dobroff, A. S., Wang, H., Melnikova, V. O., Villares, G. J., Zigler, M., Huang, L., & Bar-Eli, M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.019836 · Cited by 89
Metadata
- Authors
- Welch, D. R., Bisi, J. E., Miller, B. E., Conaway, D., Seftor, E. A., Yohem, K. H., Gilmore, L. B., Seftor, R. E. B., Nakajima, M., & Hendrix, M. J. C.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 1991-01-21
- Volume
- 47
- Issue
- 2
- Pages
- 227-237
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2048408428
- Cited by
- 190
- References
- 0
- FWCI
- 3.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.